1Deeks J J, Smith LA, bradeley MD, et al. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and theumatoid arthritis : systematic review of randomized controlled trials[J]. BMJ, 2002 , 325 (7365) :607-608.
2Steinbach G, Lynch PM,Phillips RK, et al. The effect of celecoxib , a cyclooxygenase-2 inhibitor , in familial adenomatous polyposis[J] . N Engl J Med ,2000 ,342 (26):1946-1952.
3Smakman N, Kranenburg O, Vogten JM,et al. Cyclooxygenase-2 Is a Target of KRASD12, WhichFacilitates the Outgrowth of Murine C26 Colorectal Liver Metastases[J]. Clin Cancer Res, 2005,11 ( 1 ) : 41-48.
4Lim JW, Kim H , Kim KH. Nuclear factor-kappaB regulates cyclooxygenase-2 expressioned cell proliferation in human gastric cell[J]. LabInvest,2001,81 (3) :349-360.
5A kh tarM, Cheng Y, M agno RM , et al. Promoter methylationregulates helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epthelial cells[J]. Cancer Res, 2001,61(6):2399-2403.
6Oshima M ,Murai N ,Kargman S, et al. Chemop revention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor[J]. Cancer Res, 2001,61(4):1733-1740.
7Zhang H ,Sun XF. Overexpression of cyclooxygenase-2 correlares with advanced stages of colorectal cancer[J]. Am J Gastroenterol ,2002 ,97(4):1037-1041.
8Uefuji K, Ich ikura T, Moch izuk i H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas[J]. J Surg Oncol,2001,76(1):26-30.
9ChengA S,Chan H L, ToK F. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus associated hepatocellular carcinoma[J]. Int J Oncol, 2004,24 (4) : 853-860.
10Ruegg C , Dormond O , Mariotti A. Endothelial cell integrins an COX-2 : mediators and therapeutic targets of tumor angiogenesis[J]. Biochim Biophys Acta,2004, 1654(1):51-67.
